Lisdexamfetamine dimesylate NDC 70010-215

NDC codes

FDA NDC Directory

Product NDC (as listed)70010-215Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70010-0215Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70010-215-01	70010021501	100 TABLET, CHEWABLE in 1 BOTTLE (70010-215-01)Marketed from Dec 17, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lisdexamfetamine dimesylate
Generic name (nonproprietary): lisdexamfetamine dimesylate
Active ingredients: Lisdexamfetamine dimesylate — 20 mg/1
Dosage form: Tablet, Chewable
Route: Oral
Labeler: Granules Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219258
Marketing start: Dec 17, 2024
Listing expires: Dec 31, 2027
DEA schedule: CII
Other FDA classes: Central Nervous System Stimulation (Physiologic effect)
Identifiers: Product ID 70010-215_5b7f44b7-f69e-f96d-e063-6294a90a217aSPL ID 5b7f44b7-f69e-f96d-e063-6294a90a217a
Pharmacologic class: Central Nervous System Stimulant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470010021501 followed by a unit qualifier and the quantity

Package 70010-0215-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 219258

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 219258
Product	Strength	Form · route	Labeler	Product NDC
Lisdexamfetamine dimesylate	Lisdexamfetamine dimesylate 30 mg/1	Tablet, ChewableOral	Granules Pharmaceuticals Inc.	70010-216
Lisdexamfetamine dimesylate	Lisdexamfetamine dimesylate 10 mg/1	Tablet, ChewableOral	Granules Pharmaceuticals Inc.	70010-214
Lisdexamfetamine dimesylate	Lisdexamfetamine dimesylate 60 mg/1	Tablet, ChewableOral	Granules Pharmaceuticals Inc.	70010-219
Lisdexamfetamine dimesylate	Lisdexamfetamine dimesylate 40 mg/1	Tablet, ChewableOral	Granules Pharmaceuticals Inc.	70010-217
Lisdexamfetamine dimesylate	Lisdexamfetamine dimesylate 50 mg/1	Tablet, ChewableOral	Granules Pharmaceuticals Inc.	70010-218